Lyka Labs Ltd.
Snapshot View

View in App

Prices View details >>

122.00 -1.10 ▼-0.9%

09 February 2023, 03:14:56 PM
Volume: 36,826

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.lykalabs.com
Market Cap 349.44 Cr.
Enterprise Value(EV) 485.53 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) -8.81 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-12
Industry PE 30.86 Trailing Twelve Months Ending 2022-12
Book Value / Share 1.11 Trailing Twelve Months Ending 2022-12
Price to Book Value 109.84 Calculated using Price: 121.80
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 2.87 Cr. 28,690,000 Shares
FaceValue 10
Company Profile
Lyka Labs Ltd was incorporated on December 29, 1976 as a private limited company and converted into a public limited company on December 19, 1985.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-0.89%
1 Week
-3.29%
1 Month
-5.46%
3 Month
-5.43%
6 Month
-6.58%
1 Year
-21.54%
2 Year
+296.75%
5 Year
+102.15%
10 Year
+1073.08%

Ratios View Details >>

9 years 2014-06 2015-06 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) -11.06 -13.05 11.74 -18.27 -46.30 -14.20 -448.65
Return on Capital Employed (%) 11.93 11.73 12.41 6.66 -6.52 -5.50 -31.39 8.95 56.68
Return on Assets (%) -1.72 -1.55 1.58 -2.70 -8.02 -2.97 -32.05 -5.58 21.40

Balance Sheet View Details >>

Particulars 10 years 2014-06 Rs. Cr. 2015-06 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 53 43 45 38 49 43 -14 -26 13 13
Non Curr. Liab. 65 37 29 39 5 72 137 149 73 118
Curr. Liab. 208 195 163 165 167 85 66 50 99 50
Minority Int. 3 4 4 7 3 3 -1 1 0 0
Equity & Liab. 329 279 241 249 225 203 188 174 186 182
Non Curr. Assets 211 177 159 186 176 168 152 145 133 118
Curr. Assets 118 102 82 63 49 35 36 29 52 64
Misc. Exp. not W/O
Total Assets 329 279 241 249 225 203 188 174 186 182

Profit Loss View Details >>

Particulars 10 years 2014-06 Rs. Cr. 2015-06 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 119 166 130 110 60 71 61 86 194 106
Other Income 5 2 2 2 2 2 3 2 2 4
Total Income 124 169 132 112 62 73 65 88 196 110
Total Expenditure -110 -138 -110 -87 -63 -73 -65 -67 -93 -80
PBIDT 14 31 22 25 -1 0 -1 21 103 30
Interest -29 -26 -16 -19 -10 -7 -20 -26 -20 -12
Depreciation -9 -11 -9 -10 -11 -7 -8 -8 -17 -20
Taxation -1 -1 0 2 1 9 -1 4 -21 -13
Exceptional Items 19 2 7 -4 2 -1 -33 -1 -7 -10
PAT -5 -5 4 -7 -19 -6 -63 -10 38 -25
Minority Interest -1 0 0 1 2 1 2 -1 1 0
Share Associate
Other Related Items -8
Consolidated Net Profit -14 -5 4 -6 -17 -6 -61 -12 39 -25
Adjusted EPS -7 -2 2 -3 -6 -2 -21 -4 14 -9

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-06 Rs. Cr. 2015-06 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 11 89 27 12 31 11 27 5 9 79
Cash Fr. Inv. 5 -57 29 17 -13 -3 -4 0 0 -6
Cash Fr. Finan. -13 -26 -60 -30 -19 -10 -23 3 -12 -63
Net Change 3 6 -4 -1 0 -3 -1 9 -3 10
Cash & Cash Eqvt 5 11 7 6 5 2 2 10 7 17

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 19.88 19.88 19.88 20.00 20.04 47.79 47.80 47.59 47.59
Public 80.12 80.12 80.12 80.00 79.96 52.21 52.20 52.41 52.41
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 26.76 26.76 26.76 17.95 16.98 7.12 5.53 5.12 5.12

Announcements View Details >>

Wed, 08 Feb 2023
Financial Result Updates
Lyka Labs Limited has submitted to the Exchange, the financial results for the period ended December 31, 2022.
Wed, 08 Feb 2023
Copy of Newspaper Publication
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed unaudited standalone and consolidated financial results as published on 8th February 2023 in newspapers in English ( Financial
Wed, 08 Feb 2023
Copy of Newspaper Publication
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed unaudited standalone and consolidated financial results as published on 8th February 2023 in newspapers in English ( Financial

Technical Scans View Details >>

Wed, 08 Feb 2023
Higher Trade Quantity Higher Trade Quantity
Close Below Last Week Low Close Below Last Week Low
Close Below Last Month Low Close Below Last Month Low
High Decrease in 3 Months High Decrease in 3 Months
High Increase in 2 Years High Increase in 2 Years

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 243,148.61 1,006.80 -0.6%
Cipla Ltd. 83,886.47 1,021.00 -1.7%
Dr. Reddy's Laboratories Ltd. 74,707.50 4,488.80 +0.0%
Divi's Laboratories Ltd. 74,340.49 2,824.65 +0.9%
Apollo Hospitals Enterprise Ltd. 63,077.61 4,385.00 -0.1%
Torrent Pharmaceuticals Ltd. 52,675.65 1,541.55 -1.0%
Zydus Lifesciences Ltd. 47,993.66 474.20 +0.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 57.66 1,006.80 -0.6%
Cipla Ltd. Consolidated 2022-12 31.80 1,021.00 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.50 4,488.80 +0.0%
Divi's Laboratories Ltd. Consolidated 2022-12 31.01 2,824.65 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 75.13 4,385.00 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 63.19 1,541.55 -1.0%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.29 474.20 +0.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.39 1,006.80 -0.6%
Cipla Ltd. Consolidated 2022-12 3.70 1,021.00 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.39 4,488.80 +0.0%
Divi's Laboratories Ltd. Consolidated 2022-12 5.98 2,824.65 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.54 4,385.00 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.24 1,541.55 -1.0%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.78 474.20 +0.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,006.80 -0.6%
Cipla Ltd. Consolidated 2022-03 0.04 1,021.00 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,488.80 +0.0%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,824.65 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,385.00 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,541.55 -1.0%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 474.20 +0.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,006.80 -0.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,021.00 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,488.80 +0.0%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,824.65 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,385.00 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,541.55 -1.0%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 474.20 +0.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,006.80 -0.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,021.00 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,488.80 +0.0%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,824.65 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,385.00 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,541.55 -1.0%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 474.20 +0.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,006.80 -0.6%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,021.00 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,488.80 +0.0%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,824.65 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,385.00 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,541.55 -1.0%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 474.20 +0.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,006.80 -0.6%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,021.00 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,488.80 +0.0%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,824.65 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,385.00 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,541.55 -1.0%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 474.20 +0.0%

FAQ's On Lyka Labs Ltd.

What is Lyka Labs share price?
Can I buy Lyka Labs shares now?
What is the Market Cap of Lyka Labs?
What are the key metrics to analyse Lyka Labs?
What is the 52 Week High and Low of Lyka Labs?
What is the trend of Lyka Labs share price?